Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer. - Concepedia

Concepedia

Publication | Closed Access

Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer.

101

Citations

22

References

1998

Year

N Masuda, K Matsui, S Negoro, Nobuhide Takifuji, Koji Takeda, Takashi Yana, Masao Kobayashi, T. Hirashima, Y Kusunoki, Shinichiro Ushijima,

Journal of Clinical Oncology

Abstract

A combination of CPT-11 and etoposide with rhG-CSF support is an active therapy against refractory or relapsed SCLC and deserves to be studied more extensively in a phase III trial.

References

	Year	Citations

Page 1